Diversity in Phase 2 and Phase 3 Placebo‐Controlled, Double‐Blind, Lecanemab and Elenbecestat Early Alzheimer’s Disease Studies

Alzheimer's & Dementia(2022)

引用 0|浏览8
暂无评分
关键词
elenbecestat early alzheimers,alzheimers disease,lecanemab,placebo‐controlled
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要